BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1823 related articles for article (PubMed ID: 8589618)

  • 21. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma.
    Uliasz A; Lebwohl M
    Int J Dermatol; 2007 Jun; 46(6):575-7. PubMed ID: 17550554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
    Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
    Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body site of cutaneous malignant melanoma--a study on patients with hereditary and multiple sporadic tumours.
    Gillgren P; Brattström G; Frisell J; Palmgren J; Ringborg U; Hansson J
    Melanoma Res; 2003 Jun; 13(3):279-86. PubMed ID: 12777983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
    McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
    Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
    Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
    Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998.
    Howe HL; Weinstein R; Alvi R; Kohler B; Ellison JH
    Breast Cancer Res Treat; 2005 Apr; 90(3):223-32. PubMed ID: 15830135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A profile of invasive cutaneous malignant melanoma in Malta: 1993-2002.
    Aquilina S; Dalmas M; Calleja N; Gatt P; Scerri L
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):958-63. PubMed ID: 16922945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High constant incidence rates of second primary neoplasms.
    Levi F; Boffetta P; La Vecchia C
    Eur J Cancer Prev; 2008 Oct; 17(5):385-8. PubMed ID: 18714177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).
    Kittler H; Binder M; Wolff K; Pehamberger H
    Wien Klin Wochenschr; 2001 Apr; 113(9):321-7. PubMed ID: 11388077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thick melanoma: the challenge persists.
    Murray CS; Stockton DL; Doherty VR
    Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
    Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
    J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
    Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
    Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated risk of second primary cancer in patients with cutaneous malignant melanoma: a nationwide cohort study in Taiwan.
    Hwang CY; Chen YJ; Lin MW; Chen TJ; Chu SY; Chen CC; Lee DD; Chang YT; Wan WJ; Liu HN
    J Dermatol Sci; 2010 Dec; 60(3):167-72. PubMed ID: 21036546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary cancers after cancers of the colon and rectum in New South Wales, Australia, 1972-1991.
    McCredie M; Macfarlane GJ; Bell J; Coates M
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):155-60. PubMed ID: 9138657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
    Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
    Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evidence base for reconsidering current follow-up guidelines for patients with cutaneous melanoma less than 0.5 mm thick at diagnosis.
    Einwachter-Thompson J; MacKie RM
    Br J Dermatol; 2008 Aug; 159(2):337-41. PubMed ID: 18510665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
    Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
    J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple primary melanoma: two-year results from a population-based study.
    Titus-Ernstoff L; Perry AE; Spencer SK; Gibson J; Ding J; Cole B; Ernstoff MS
    Arch Dermatol; 2006 Apr; 142(4):433-8. PubMed ID: 16618861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 92.